Moderating the Myosin Motor to Treat Hypertrophic Cardiomyopathy

JACC Basic Transl Sci. 2022 Aug 22;7(8):776-778. doi: 10.1016/j.jacbts.2022.06.006. eCollection 2022 Aug.
No abstract available

Keywords: aficamten; direct myosin activators; direct myosin inhibitors; hypertrophic cardiomyopathy; mavacamten; myosin heavy chain β; negative inotropy; omecamtiv mecarbil; pharmacologic therapy; positive inotropy.

Publication types

  • Editorial